Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol-Enhanced MRI in Pediatric Brain Tumors
NCT03179449Phase 1Withdrawn
- Start
- Jul 2017
- Primary completion
- Jun 2025
- Modality
- Nanoparticles, Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of ferumoxytol in brain neoplasm. Primary endpoint: Iron concentration measurements at Day 1. Planned start Jul 2017; status: withdrawn.
02
Drugs
ferumoxytol
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on NCT03179449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03179449.